Top Markets
#1 Black Phoenix Black Phoenix +829.97%
#2 pipedog pipedog +41.42%
#3 PondCoin PondCoin +34.34%
#4 Bless Bless +32.22%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.74%
#6 SAFEcoin SAFEcoin +26.51%
#7 Beam Beam +24.69%
#8 Seeker Seeker +21.01%
#9 Magma Finance Magma Finance +20.64%
#10 YFSX YFSX +16.15%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
주식 순위 #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
주가
$64.97
마지막 동기화: 2024-05-20
시가총액
$1.97B
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Alpine Immune Sciences, Inc. (ALPN)

카테고리

Healthcare
Alpine Immune Sciences, Inc. (ALPN)의 발행 주식 수
March 2024 기준 발행 주식 수: 64.03M
Alpine Immune Sciences, Inc.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 64.03M입니다. December 2022 말 기준 회사는 33.44M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Alpine Immune Sciences, Inc. (ALPN)의 발행 주식 수 기록 (2012 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 64.03M 28.07%
2023 50.00M 49.54%
2022 33.44M 31.24%
2021 25.48M 22.33%
2020 20.83M 13.44%
2019 18.36M 32.56%
2018 13.85M 113.67%
2017 6.48M 67.36%
2016 3.87M 65.32%
2015 2.34M 2.70%
2014 2.28M 0.00%
2013 2.28M 0.00%
2012 2.28M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 296.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -2.89%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 647.91%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 518.43%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH